2017
DOI: 10.1016/j.ypmed.2017.10.011
|View full text |Cite
|
Sign up to set email alerts
|

Cost effectiveness and return on investment of a scalable community weight loss intervention

Abstract: This study assessed the lifetime health and economic consequences of an efficacious scalable community weight loss program for overweight and obese adults. We applied a state-transition Markov model to project lifetime economic outcome (US dollar) and the degree of disease averted as a result of a weight loss intervention, compared with no intervention, from a payer perspective. Effect sizes of the intervention on weight loss, by sex, race and ethnicity, and body mass index (BMI) of participants, were derived … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 53 publications
0
5
0
Order By: Relevance
“…Demographic factors (e.g., identity and economic) are more easily and frequently collected than more actionable factors. However, interventions for behavioral-related SDoH factors are more feasible and have demonstrated examples of high ROI (ROI range, $7.60 to $16.70 returned for every US dollar spent) to promote healthy eating and weight loss [39,40]. Policy recommendations [8,17] to prioritize other actionable SDoH factors such as education, food, and housing in targeted interventions show reduced costs [41][42][43].…”
Section: Discussionmentioning
confidence: 99%
“…Demographic factors (e.g., identity and economic) are more easily and frequently collected than more actionable factors. However, interventions for behavioral-related SDoH factors are more feasible and have demonstrated examples of high ROI (ROI range, $7.60 to $16.70 returned for every US dollar spent) to promote healthy eating and weight loss [39,40]. Policy recommendations [8,17] to prioritize other actionable SDoH factors such as education, food, and housing in targeted interventions show reduced costs [41][42][43].…”
Section: Discussionmentioning
confidence: 99%
“…The secondary outcomes include absolute weight loss achieved at 3, 6, 9, and 12 months, respectively, and the percent of participants achieving clinically significant weight loss (≥3%, ≥5%, or ≥7% of the initial bodyweight). Additionally, we will collect intervention cost data using all program invoices related to program implementation and further grouped into technical systems support, program delivery personnel, kiosk leasing, marketing personnel and activities, and program incentives as categorized in our previous cost-effectiveness assessment of the program [34].…”
Section: Study Outcomesmentioning
confidence: 99%
“…Weight loss regained immediately. Eight HEMs [35][36][37][38][39][40][41][42] assumed that the intervention effect ceased after the trial follow-up and that those receiving the intervention immediately returned to the same weight as the control group. From this point onward, there was no weight difference between the intervention and control groups; their weight either remained at that value for the remainder of the time horizon [35][36][37][38][39]42 or followed a natural history trajectory 40,41 (Figure 2b).…”
Section: Assumptions Made About Weight Trajectoriesmentioning
confidence: 99%
“…Thirty HEMs cited an evidence source for estimated weight loss that reported no measurement of psychosocial variables. [24][25][26][27][28][29][30][31][32][33][35][36][37][38][39][40]42,44,46,[49][50][51][52]55,56,58,59,61,62,68 Psychosocial variables were measured in evidence sources cited in 8 HEMs (Table 3); 4 of these HEMs 43,45,48,53 each based the estimated weight loss on a single trial, but no analyses of the psychosocial variables measured in relation to the intervention or weight change were reported in the trial. Four HEMs 23,34,41,47 cited 5 trials that included some analysis of psychosocial factors.…”
Section: Trial 69mentioning
confidence: 99%